tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

PMV Pharmaceuticals Inc

PMVP
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
1.315USD
-0.055-4.01%
์‹œ์žฅ ์šด์˜ ์‹œ๊ฐ„ย 09/24, 10:42๏ผˆET๏ผ‰
70.13M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

PMV Pharmaceuticals Inc

1.315
-0.055-4.01%
๊ฐœ์š”
๋‰ด์Šค & ๋ถ„์„
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๋‰ด์Šค & ๋ถ„์„

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

PMVP ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด PMV Pharmaceuticals Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
70.13M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-0.89
์ฃผ๋‹น์ˆœ์ด์ต
-1.48
์ˆ˜์ต
--
์ˆœ์ด์ต
-58.71M
ROE
-63.16%
ROA
-58.65%

PMV Pharmaceuticals Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 14, 2026
EPS / ์˜ˆ์ƒ
-0.34/-0.39
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
16.93%-0.34
-0.77%-0.34
23.62%-0.34
-6.60%-0.40
-1630.90%-0.41
-13.07%-0.34
-44.77%-0.44
-9.88%-0.37
93.81%-0.02
28.97%-0.30
27.56%-0.31
---0.34
---0.38
---0.42
---0.42
---1.18
----
----
----
----
์ˆœ์ด์ต
14.73%-18.09M
-3.45%-18.04M
21.58%-18.04M
-9.53%-21.06M
-1648.56%-21.21M
-14.18%-17.44M
-45.98%-23.00M
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
-5.37%-19.34M
-21.44%-18.23M
-34.46%-17.31M
-58.88%-18.43M
-75.62%-18.36M
-71.28%-15.01M
์†์ต๊ณ„์‚ฐ์„œ๎˜
์˜์—… ์ด์ต
17.47%-18.88M
11.80%-19.02M
23.55%-19.24M
-2.90%-22.52M
-13.43%-22.88M
-18.35%-21.56M
-33.15%-25.17M
-11.51%-21.89M
-0.24%-20.17M
15.17%-18.22M
10.68%-18.90M
-1.31%-19.63M
-12.51%-20.12M
-15.37%-21.48M
-14.56%-21.16M
-28.34%-19.38M
-37.05%-17.89M
-59.49%-18.62M
-75.91%-18.47M
-73.51%-15.10M
์ˆœ์ด์ต
14.73%-18.09M
-3.45%-18.04M
21.58%-18.04M
-9.53%-21.06M
-1648.56%-21.21M
-14.18%-17.44M
-45.98%-23.00M
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
-5.37%-19.34M
-21.44%-18.23M
-34.46%-17.31M
-58.88%-18.43M
-75.62%-18.36M
-71.28%-15.01M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
-43.98%81.41M
-41.42%95.78M
-34.40%115.23M
-30.15%132.45M
-33.58%145.31M
-19.24%163.50M
-15.31%175.66M
-7.64%189.62M
14.90%218.79M
-13.21%202.46M
-16.03%207.41M
-22.58%205.30M
-32.45%190.41M
-19.01%233.28M
-18.02%247.01M
-15.43%265.18M
-12.76%281.87M
-14.01%288.04M
-17.40%301.29M
-16.09%313.56M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
-8.95%10.57M
-11.93%8.60M
-20.56%11.41M
-9.28%12.30M
1.95%11.61M
-19.07%9.76M
2.43%14.37M
26.57%13.56M
-0.54%11.38M
13.86%12.06M
29.51%14.03M
-8.06%10.72M
0.56%11.45M
-9.37%10.59M
-11.35%10.83M
36.12%11.66M
51.69%11.38M
101.60%11.69M
90.62%12.22M
56.37%8.56M
์ด ์ž์‚ฐ
-46.31%82.07M
-43.40%96.56M
-39.06%116.56M
-40.11%133.84M
-35.65%152.85M
-27.98%170.61M
-24.14%191.29M
-14.38%223.50M
-1.93%237.54M
-6.73%236.88M
-6.72%252.15M
-8.41%261.03M
-19.41%242.22M
-19.38%253.96M
-18.48%270.31M
-17.20%284.98M
-15.55%300.56M
-11.11%315.01M
-9.29%331.57M
-8.08%344.18M
๋ถ€์ฑ„ ์ด๊ณ„
-13.73%10.57M
-18.15%8.60M
-22.08%11.85M
-49.80%12.85M
-47.25%12.25M
-56.61%10.50M
-42.53%15.21M
9.28%25.59M
-4.85%23.22M
1.74%24.20M
8.99%26.46M
-1.58%23.41M
3.45%24.41M
2.69%23.79M
5.52%24.28M
23.72%23.79M
30.62%23.59M
279.88%23.16M
258.95%23.01M
251.17%19.23M
์ž๋ณธ ์ด๊ณ„
-49.15%71.50M
-45.06%87.97M
-40.53%104.71M
-38.86%121.00M
-34.39%140.60M
-24.72%160.11M
-21.98%176.08M
-16.71%197.91M
-1.60%214.31M
-7.60%212.68M
-8.27%225.69M
-9.03%237.61M
-21.36%217.81M
-21.13%230.17M
-20.27%246.03M
-19.62%261.19M
-18.02%276.97M
-16.21%291.84M
-14.08%308.56M
-11.93%324.95M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
20.35%-14.58M
-7.74%-19.68M
-3.17%-17.19M
-17.70%-19.82M
-1045.31%-18.30M
-12.86%-18.27M
-37.87%-16.66M
-7.54%-16.84M
87.61%-1.60M
-7.81%-16.18M
21.14%-12.09M
6.56%-15.66M
5.69%-12.90M
16.59%-15.01M
-27.40%-15.32M
-35.18%-16.76M
-48.03%-13.68M
-39.48%-18.00M
-16.64%-12.03M
-67.70%-12.40M
์ˆœํˆฌ์ž
-211.30%-12.23M
-27.48%20.82M
138.17%18.44M
-29.74%12.03M
372.92%10.99M
9.74%28.71M
399.23%7.74M
150.89%17.12M
103.63%2.32M
-47.29%26.17M
-111.14%-2.59M
-213.98%-33.64M
-318.63%-63.96M
227.87%49.65M
207.22%23.22M
4358.73%29.51M
-44.78%-15.28M
72.25%-38.83M
13361.40%7.56M
-108.62%-693.00K
์ˆœ์žฌ๋ฌดํ™œ๋™
38.83%143.00K
-100.00%0.00
127.91%392.00K
--0.00
-26.95%103.00K
--10.00K
-40.28%172.00K
-100.00%0.00
-93.38%141.00K
-100.00%0.00
-47.45%288.00K
552333.33%33.15M
672.10%2.13M
-90.63%12.00K
85.76%548.00K
-98.06%6.00K
-78.03%276.00K
-20.99%128.00K
121.71%295.00K
-99.90%309.00K

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

PMV Pharmaceuticals Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
PMV Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 115.23M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -34.40์ž…๋‹ˆ๋‹ค.

PMV Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
PMV Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, PMV Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ 116.56M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -39.06์ž…๋‹ˆ๋‹ค.

PMV Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
PMV Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, PMV Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” 11.85M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -22.08์ž…๋‹ˆ๋‹ค.

PMV Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
PMV Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, PMV Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ 104.71M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -40.53์ž…๋‹ˆ๋‹ค.

PMV Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
PMV Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, PMV Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -86.21M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -0.89์ž…๋‹ˆ๋‹ค.

PMV Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
PMV Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, PMV Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” 70.17M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 31.53์ž…๋‹ˆ๋‹ค.

PMV Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
PMV Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, PMV Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 505.00K์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 61.34์ž…๋‹ˆ๋‹ค.

PMV Pharmaceuticals Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
PMV Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -1.48์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -29.99์ž…๋‹ˆ๋‹ค.

PMV Pharmaceuticals Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
PMV Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -77.74M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -32.42์ž…๋‹ˆ๋‹ค.

PMV Pharmaceuticals Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
PMV Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -55.37์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -89.47์ž…๋‹ˆ๋‹ค.

PMV Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
PMV Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -50.51์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -90.74์ž…๋‹ˆ๋‹ค.

PMV Pharmaceuticals Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
PMV Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -86.21M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -0.89์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ